Navigation Links
Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
Date:8/19/2007

steady flow of clinical information in the second half of 2007 as our clinical studies progress to broader populations."

About Trodusquemine (MSI-1436)

Trodusquemine (MSI-1436) is the first drug candidate that acts both centrally and peripherally to selectively inhibit the established and validated enzyme target, protein tyrosine phosphatase 1B (PTP-1B). The dual locations of MSI-1436 action make the drug a promising candidate for both obesity and type 2 diabetes. By inhibiting PTP-1B, trodusquemine is expected to decrease appetite and normalize blood sugar as PTB-1B is central to both the insulin and leptin pathways. Based on this unique mechanism of action, trodusquemine has the potential to bridge the treatment for two of the most serious metabolic diseases, obesity and type 2 diabetes. In addition, trodusquemine has overcome selectivity concerns that other compounds that target PTP-1B have failed to overcome. Preclinical studies demonstrate that trodusquemine is a potent, highly-selective and reversible inhibitor of PTP-1B. In vitro kinetics demonstrate that trodusquemine is an allosteric, noncompetitive inhibitor of PTP-1B, binding to a site different from the catalytic site of PTP-1B. Data also demonstrate that trodusquemine can produce consistent, sustainable weight loss in a variety of animal models and appears to overcome metabolic readjustment, which often limits sustained weight loss during caloric restriction. Trodusquemine suppresses appetite, causes differential weight loss, reduces adipocyte size, reduces body fat (with no reduction of lean mass), and improves glucose tolerance via inhibition of a unique combination of signaling pathways in a mouse model of diet induced obesity (DIO).

About Genaera

Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefin
'/>"/>

SOURCE Genaera Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
2. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
3. Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
4. Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
5. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
6. Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
7. EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... DIEGO , Sept. 2, 2015  Neurocrine Biosciences, ... Tim Coughlin , Chief Financial Officer of Neurocrine Biosciences, ... in New York City . ... 9 at 11:25am ET (8:25am PT).  The presentation will ... website at http://www.neurocrine.com .   Listeners ...
(Date:9/2/2015)... 2, 2015 Research and Markets ( ... PharmaBiotech,s new report "Drug Delivery in Central ... to their offering. Advances ... BBB have opened new avenues and possibilities for ... or transport systems, enzymes, and receptors that control ...
(Date:9/2/2015)... Demers Ambulances is proud to announce it has signed Emergency ... states of Mississippi , Alabama ... "This will enable Demers to effectively meet the needs ... for Demers Ambulances. "Emergency Equipment Professionals has three service centers ... Alabama , giving them a strategic advantage. Local service ...
Breaking Medicine Technology:Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 3Demers Ambulances has named Emergency Equipment Professionals (EEP) Inc. as their dealer for the states of MS, AL and TN 2
... NASHVILLE, Tenn., Nov. 23 Cumberland Pharmaceuticals Inc. ( ... from a study evaluating the safety and efficacy of Caldolor ( ... Statistical significance was achieved for the primary endpoint of reducing fever ... study evaluated 61 adult burn patients with second or third degree ...
... , INDIANAPOLIS, Nov. 23 AMD LASERS ... commitment to dental education by partnering with prestigious industry-leader ... AMD LASERS, will be the exclusive soft tissue diode ... targeted to the top 2% of dentists. , (Photo: ...
Cached Medicine Technology:Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage 2
(Date:9/2/2015)... , ... September 02, 2015 , ... ... Things, announces its latest addition to its screen mirroring and extending product line ... Extended Wireless Display, which operates in local WIFI setting, the new Splashtop Wired ...
(Date:9/2/2015)... ... ... The medical waste management market is expected to reach USD 13.3 billion by 2020 ... waste management market is segmented based on type of waste, services, treatment type, treatment ... growth rate in the medical waste management market, by service, during the forecast period. ...
(Date:9/2/2015)... PA (PRWEB) , ... September 02, 2015 , ... ... Health Sciences clinical and academic partnership has earned international recognition as a premier ... genetic disorder that can cause sudden, catastrophic internal bleeding and stroke. , ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... Center at Children's Healthcare of Atlanta to help support childhood cancer research. ... the upcoming WSB Radio Care-A-Thon , which is the fund-raising event DoMyOwnPestControl.com ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... Benefit Administrators is taking action after seeing a significant increase in unlawful ... Claim Review division has found many cases of OON ASCs encouraging members to ...
Breaking Medicine News(10 mins):Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 2Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 4Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 5Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3
... of Infection and ... Appropriate Treatment, ... announced the launch of a new educational module "Chronic Wound,Infections", ... and enhance treatment for improved clinical,outcomes., Chronic wounds substantially ...
... ALTO, Calif., June 30 Facebook today announced,that ... Currently,co-founder and chairman at Ning, Andreessen is an ... industry leader, and we,re fortunate to have him ... Zuckerberg. "He has experience,that is relevant to Facebook ...
... new or renovated rooms; Unity and ... patients, ROCHESTER, N.Y., June 30 The state should,support ... an,additional 140 beds -- more than 50 of which could ... to a commission convened by,Finger Lakes Health Systems Agency., ...
... SMBL ) announced today that it has been ... Russell,Investments reconstituted its comprehensive set of U.S. and global ... be included in the Russell indexes, which will,increase the ... potential,investors," said Robert S. Gluck, Vice Chairman and Chief ...
... WASHINGTON, June 30 The Justice Department,announced today ... the care,given to residents of the Beatrice State ... residential facility that serves almost 300,persons with mental ... and subject to the approval of the U.S. ...
... fact , , MONDAY, June 30 (HealthDay News) -- A new study ... loss of memory. , The study, which has followed thousands of ... of memory on a word test for those at age 55 ... levels. By age 60, the rate of memory loss had increased ...
Cached Medicine News:Health News:The Wound Institute(R) Launches Educational Course on Chronic Wound Infections 2Health News:The Wound Institute(R) Launches Educational Course on Chronic Wound Infections 3Health News:The Wound Institute(R) Launches Educational Course on Chronic Wound Infections 4Health News:Marc Andreessen Joins Facebook Board of Directors 2Health News:2020 Commission Supports Modernization Plans at Three Monroe County Hospitals, With 140 Additional Beds 2Health News:2020 Commission Supports Modernization Plans at Three Monroe County Hospitals, With 140 Additional Beds 3Health News:2020 Commission Supports Modernization Plans at Three Monroe County Hospitals, With 140 Additional Beds 4Health News:Smart Balance Added to Russell 2000 and 3000 Indexes 2Health News:Justice Department Reaches Settlement to Improve Conditions at a Nebraska Developmental Center 2Health News:Research Links Low HDL Levels With Memory Loss 2
Histopathology Reference Laboratory provides a full range of histology services, encompassing routine and specialized grossing, processing, embedding, microtomy, routine and special staining and cove...
IBT Reference Laboratory is a national research and specialty clinical lab founded in 1983 that provides a wide range of tests and services in the area of allergy, clinical immunology and molecular b...
Marquette General Health System Reference Laboratory provides a full range of testing including, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, Cytology, Anatomic Pathology, Flow Cytom...
Headquartered in Burlington, North Carolina, LabCorp has more than 23,500 employees and offers more than 4,400 clinical tests ranging from routine blood analyses to the most sophisticated molecular d...
Medicine Products: